K. Tay

Multi-institutional Patient-level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence (MMAI) in Prostate Cancer.

IMPORTANCE The Decipher Prostate Genomic Classifier (GC) and ArteraAI Multimodal Artificial Intelligence (MMAI) platform are widely used prognostic tools for localized prostate cancer (PCa), yet no direct comparison has been performed within the same patient cohort. METHODS We sought to evaluate the concordance and p...

Impact of magnetic resonance imaging-based diagnostic pathway on oncologic outcomes of localised prostate cancer between primary treatment modalities: a Will-Rogers phenomenon?

Evaluating trends in treatment and outcomes of stage I renal cell carcinoma with machine learning: The RECLAIM-L (REnal cancer landscape and artificial intelligence with machine learning) database

Treatment selection for localized renal cell carcinoma (RCC) has progressed significantly in recent years. We aim to describe clinicopathological characteristics and treatment outcomes of clinical stage I RCC patients, and construct machine learning (ML) models for personalized prediction of survival outcome...